Five-Year Postmarket Safety Experience With the Optimal Balance Technology Range of Hyaluronic Acid Fillers-Reference-Cited by-同舟云学术

Five-Year Postmarket Safety Experience With the Optimal Balance Technology Range of Hyaluronic Acid Fillers

Published:2020-01 Issue:1 Volume:46 Page:145-147
ISSN:1076-0512
Container-title:Dermatologic Surgery
language:en
Short-container-title:DS

Author:

Jones Derek H.,Bank David,Jacobsson Josefin,Koltowska-Häggström Maria,Wong Cindy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Dermatology,General Medicine,Surgery

Reference5 articles.

1. Use of hyaluronic acid fillers for the treatment of the aging face;Gold;Clin Interv Aging,2007

2. Global Aesthetics Consensus: Avoidance and management of Complications from hyaluronic acid fillers-Evidence- and Opinion-based Review and Consensus Recommendations;Signorini;Plast Reconstr Surg,2016

3. A complete range of hyaluronic acid filler with distinctive physical properties specifically designed for optimal tissue adaptations;Segura;J Drugs Dermatol,2012

4. Delayed-onset nodules secondary to a smooth cohesive 20 mg/mL hyaluronic acid filler: cause and management;Beleznay;Dermatol Surg,2015

5. Resistant and Recurrent late Reaction to hyaluronic acid-based gel;Artzi;Dermatol Surg,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Suitability of a Large Particle Hyaluronic Acid Filler for the Treatment of Temporal Hollowing;Dermatologic Surgery;2023-09-15

2. Hyaluronidase Availability in Emergency Rooms: A Statewide Analysis;Facial Plastic Surgery & Aesthetic Medicine;2023-04-01

3. Ten-Year Global Postmarket Safety Surveillance of Delayed Complications With a Flexible Cheek Filler;Dermatologic Surgery;2022-09-15

4. In vitro inflammatory and immune response to uncrosslinked hyaluronic acid (HA) and HA fillers;Journal of Immunology and Regenerative Medicine;2022-08

5. Hyaluronic Acid Fillers;Cosmetic Dermatology;2022-02-04